Publication | Closed Access

Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway

InflammationAnti-inflammatoryMitochondria-nlrp3 Inflammasome-microglia ChannelImmune Cell Development3×Tg-ad MiceMedicineImmunologyImmune RegulationChronic InflammationP38 MapkDegenerative PathologyBrain-immune InteractionNeuroimmunologyCell BiologyCell SignalingCellular PhysiologyMolecular SignalingNeuroinflammation